Have you or your loved ones been diagnosed with fatigue?

You may be eligible to participate in a fatigue clinical trial.

Have you or your loved ones been diagnosed with fatigue? You may be eligible to participate in a fatigue clinical trial.

What is a clinical trial? Is participating in a clinical trial right for you? Learn more

Recruiting for this study? Get access to patient recruitment tools.
Fatigue Clinical Trial in New York NY
NCT03891667 | Phase 1 phase 2 | Interventional

Have you or your loved ones been diagnosed with fatigue?

You may be eligible to participate in a fatigue clinical trial.

Have you or your loved ones been diagnosed with fatigue? You may be eligible to participate in a fatigue clinical trial.

Recruiting

Male & Female

18 - 65

Years old

This study is looking to recruit 24 Participants

Approximately 10-20% of patients experience ongoing symptoms despite having received standard antibiotic therapy for Lyme disease. Possible explanations for persistent symptoms include persistent infection and/or post-infectious causes. Recent in vitro studies indicate that disulfiram is effective at killing both the actively replicating and the more quiescent persister forms of Borrelia burgdorferi, the microbe that causes Lyme Disease. In this study, the investigators are examining the safety of disulfiram among patients with post-treatment Lyme disease symptoms. The investigators are also conducting a preliminary investigation regarding the relative benefit of 4 vs 8 weeks of treatment with disulfiram.

Step 1 of 4: Email
Selected location

Lyme Research Center New York State Psychiatric Institute

New York, NY, USA 10032


The information you provide is confidential and is never sold or shared with outside vendors. By clicking the button, you agree to the PatientWing's Terms and Privacy Policy.